Scandion Oncology
BioTech/Drugs - N/A, N/A, DK
Scandion Oncology Employees
Scandion Oncology Senior Management
Scandion Oncology Details
Scandion Oncology A/S is a listed Danish biotechnology company with the mission to address one of the most important challenges in modern oncology - the effective treatment of cancer which has developed resistance towards existing cancer medicine. The company's first-in-class lead compound, SCO-101, is an add-on to chemotherapy and is currently in clinical phase I and II studies in cancer patients. The company also has several preclinical programs to build a broader pipeline of drugs for the treatment of drug resistant cancer diseases.
Website:
scandiononcology.com
Employees:
5 - 9
HQ:
N/A
Location:
N/A, N/A, DK
Revenue:
Not Available
Scandion Oncology Technologies
Email Providers
Outlook
Marketing Automation
Active Campaign
CMS
WordPress.org
Tag Management
Google Tag Manager
Other
Cision